ZIKV E antibody

Catalog No. ABIN7383928

The Mouse Monoclonal anti-ZIKV E antibody (Clone 9) (ABIN7383928) specifically detects ZIKV E in ELISA and WB. The antibody is reactive with Zika Virus (ZIKV) samples.

Quick Overview for ZIKV E antibody (ABIN7383928)

Target: ZIKV E (Zika Virus Envelope (ZIKV E))

Reactivity: Zika Virus (ZIKV)

Host: Mouse

Clonality: Monoclonal

Conjugate: This ZIKV E antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Clone: 9

Product Details anti-ZIKV E Antibody

Specificity: Anti-Zika virus(ZIKV)(strain Zika SPH2015) ZIKV-E/Envelope Protein Monoclonal Antibody

Purification: Protein A Affinity

Immunogen: Recombinant ZIKV (strain Zika SPH2015) Envelope protein (Domain III, His Tag), ABIN7198753

Isotype: IgG1

Application Details

Application Notes: WB 1:1000-1:5000 ELISA 1:1000-1:2000

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: 0.2 μm filtered solution in PBS

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for ZIKV E

Target: ZIKV E (Zika Virus Envelope (ZIKV E))

Alternative Name: ZIKV Envelope Protein

Background: E,Envelope Protein,Envelope of Zika virus is resposible for receptor binding and membrane. Analysis of the envelope protein of Zika, from Brazilian Zika SPH215 (KU321639), indicates predicted B and T cell epitopes in peptides that are consistent to those reported for dengue, YFYF and Japanese encephalitis. The envelope Domain II B cell epitope, to which much dengue non-neutralizing cross reaction is attributed, is also conserved also in Zika virus, consistent with prior field observations of cross reactivity with dengue and YF. Domain III of the Zika envelope protein, likely the main specific neutralizing domain, is distinct from recent Brazilian dengue isolates and a recent Peruvian YF isolate (GQ379163), 76 % of possible major histocompatibility complex class (MHC) I and MHC II binding peptides and potential B cell linear epitopes are unique to Zika virus.